Figure 3From: Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder Posterior predictive check for change from baseline in mean voided volume (MVV) after taking placebo or fesoterodine 4 mg, 8 mg, or 12 mg.Back to article page